Coegin Pharma AB (NGM:COEGIN)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.460
-0.190 (-5.21%)
At close: May 28, 2025
-32.16%
Market Cap 93.79M
Revenue (ttm) -509.00K
Net Income (ttm) -19.58M
Shares Out 24.88M
EPS (ttm) -0.92
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 36,621
Average Volume 27,227
Open n/a
Previous Close 3.650
Day's Range n/a
52-Week Range 3.460 - 8.300
Beta 0.99
RSI 47.48
Earnings Date May 22, 2025

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate whic... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol COEGIN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.